Premium
The demographics of adverse outcomes in cystic fibrosis
Author(s) -
McGarry Meghan E.,
Williams Wadsworth A.,
McColley Susanna A.
Publication year - 2019
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.24434
Subject(s) - cystic fibrosis , medicine , demographics , psychological intervention , intensive care medicine , health care , adverse effect , environmental health , nursing , demography , sociology , economic growth , economics
Understanding variability in cystic fibrosis (CF) health outcomes requires an understanding of factors that go far beyond Cystic Fibrosis Transmembrane Receptor (CFTR) function caused by different gene mutations. Social and environmental factors that influence health have a significant influence on the trajectory of health in CF and in other chronic diseases. In this article, we review demographic factors associated with poorer health outcomes in CF, known and postulated biological mechanisms of these outcomes, and interventions that healthcare teams can implement that may reduce outcome disparities.